Pirazolac
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384616This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H12ClFN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FWY2578LP5, chemically known as 1h-pyrazole-3-acetic acid, 4-(4-chlorophenyl)-1-(4-fluorophenyl)- but generally known as pirazolac, which bears US NIH Compound Identifier 51222. European Medicines Agency schedules Pirazolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09898MIG. The term PIRAZOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). PIRAZOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirazolac under HS 29331990 and SITC 51571. As of Q4 2014, PIRAZOLAC remains the US FDA Preferred Term for this commodity. Pirazolac bears US NLM identifiers UMLS ID C0071127 and NCI Concept Code C66413. SMILES: CLC1CCC(C2C(NN(C2)C2CCC(F)CC2)CC(=O)O)CC1.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.